GFAP and epilepsy: Like KA-induced epilepsy mouse model, pilocarpine-treated rats exhibited increased GFAP expression in the hippocampal CA1 region, accompanied by a marked decrease in GS expression in GFAP-positive astrocytes (Fig. 9a, c, d).